BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217117. A total of 32 filers reported holding BIOPLUS ACQUISITION CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,597,500 | – | 150,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 66,607 | $685 | 1.08% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,482,836 | $15,244 | 0.42% |
| MMCAP International Inc. SPC | 400,000 | $4,088,000 | 0.42% |
| CANTOR FITZGERALD, L. P. | 1,422,204 | $14,557 | 0.31% |
| KIM, LLC | 500,000 | $5,140 | 0.28% |
| Spartan Fund Management Inc. | 74,485 | $763 | 0.28% |
| Saba Capital Management, L.P. | 1,791,845 | $18,384,330 | 0.25% |
| Atalaya Capital Management LP | 125,000 | $1,285,000 | 0.23% |
| Radcliffe Capital Management, L.P. | 555,355 | $5,697,942 | 0.18% |
| Exos TFP Holdings LLC | 62,500 | $638,750 | 0.18% |